Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial
Aghajanian, Carol, Swisher, Elizabeth M., Okamoto, Aikou, Steffensen, Karina Dahl, Bookman, Michael A., Fleming, Gini F., Friedlander, Michael, Moore, Kathleen N., Tewari, Krishnansu S., O'Malley, David M., Chan, John K., Ratajczak, Christine, Hashiba, Hideyuki, Wu, Meijing, Dinh, Minh H., Coleman, Robert L.
Published in Gynecologic oncology (01.02.2022)
Published in Gynecologic oncology (01.02.2022)
Get full text
Journal Article
Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer
Nishio, Shin, Takekuma, Munetaka, Takeuchi, Satoshi, Kawano, Kouichirou, Tsuda, Naotake, Tasaki, Kazuto, Takahashi, Nobutaka, Abe, Masakazu, Tanaka, Aki, Nagasawa, Takayuki, Shoji, Tadahiro, Xiong, Hao, Nuthalapati, Silpa, Leahy, Terri, Hashiba, Hideyuki, Kiriyama, Tsukasa, Komarnitsky, Philip, Hirashima, Yasuyuki, Ushijima, Kimio
Published in Cancer science (01.11.2017)
Published in Cancer science (01.11.2017)
Get full text
Journal Article
Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors
Nishikawa, Tadaaki, Matsumoto, Koji, Tamura, Kenji, Yoshida, Hiroyuki, Imai, Yuichi, Miyasaka, Aki, Onoe, Takuma, Yamaguchi, Satoshi, Shimizu, Chikako, Yonemori, Kan, Shimoi, Tatsunori, Yunokawa, Mayu, Xiong, Hao, Nuthalapati, Silpa, Hashiba, Hideyuki, Kiriyama, Tsukasa, Leahy, Terri, Komarnitsky, Philip, Fujiwara, Keiichi
Published in Cancer science (01.09.2017)
Published in Cancer science (01.09.2017)
Get full text
Journal Article
Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial
Mizuno, Mika, Ito, Kimihiko, Nakai, Hidekatsu, Kato, Hidenori, Kamiura, Shoji, Ushijima, Kimio, Nagao, Shoji, Takano, Hirokuni, Okadome, Masao, Takekuma, Munetaka, Tokunaga, Hideki, Nagase, Satoru, Aoki, Daisuke, Coleman, Robert L., Nishimura, Yasuko, Ratajczak, Christine K., Hashiba, Hideyuki, Xiong, Hao, Katsumata, Noriyuki, Enomoto, Takayuki, Okamoto, Aikou
Published in International journal of clinical oncology (01.01.2023)
Published in International journal of clinical oncology (01.01.2023)
Get full text
Journal Article
Preliminary Phase 1 Results of the PD-1 Inhibitor ABBV-181 in Japanese vs Western Patients With Advanced Solid Tumors
Kuboki, Yasutoshi, Kondo, Shunsuke, Drew, Rasco, John, Powderly, Alexander, Spira, luke Jason, J., Daniel, Afar, Stefan, Englert, Hashiba, Hideyuki, Stacie, Lambert, Apurvasena, Parikh, Shimizu, Eisuke, Greg, Vosganian, Doi, Toshihiko, Yamamoto, Noboru
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
MO2-12-4Preliminary Phase 1 Results of the PD-1 Inhibitor ABBV-181 in Japanese vs Western Patients With Advanced Solid Tumors
Kuboki, Yasutoshi, Kondo, Shunsuke, Drew, Rasco, John, Powderly, Alexander, Spira, luke Jason, J, Daniel, Afar, Stefan, Englert, Hashiba, Hideyuki, Stacie, Lambert, Apurvasena, Parikh, Shimizu, Eisuke, Greg, Vosganian, Doi, Toshihiko, Yamamoto, Noboru
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC)
Mizugaki, Hidenori, Yamamoto, Noboru, Nokihara, Hiroshi, Fujiwara, Yutaka, Horinouchi, Hidehito, Kanda, Shintaro, Kitazono, Satoru, Yagishita, Shigehiro, Xiong, Hao, Qian, Jane, Hashiba, Hideyuki, Shepherd, Stacie P., Giranda, Vincent, Tamura, Tomohide
Published in Cancer chemotherapy and pharmacology (01.11.2015)
Published in Cancer chemotherapy and pharmacology (01.11.2015)
Get full text
Journal Article